Diphtheria Market: Comprehensive Review of Vaccination Strategies, Market Size, and Future Trends

The new report published by The Business Research Company, titled Diphtheria Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the diphtheria market size has grown strongly in recent years. It will grow from $8.34 billion in 2023 to $8.91 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The diphtheria market size is expected to see strong growth in the next few years. It will grow to $11.51 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13016&type=smp

Rising Prevalence Of Bacterial Infections Fuels Growth In The Diphtheria Market
The rising prevalence of bacterial infections is expected to propel the growth of the diphtheria market going forward. A bacterial infection is a sickness or condition attributed to bacterial growth or the toxins produced by bacteria that invade the body. Diphtheria is a serious infection caused by bacteria strains that suppress the immune system and promote the proliferation of Corynebacterium diphtheria. For instance, in November 2022, according to a report published by the European Centre for Disease Prevention and Control, a Sweden-based public health organization, the number of reported infections of Acinetobacter species resistant to various antimicrobial groups was over doubled (+121%) the average in the year 2021 and more than 35,000 people die from antimicrobial-resistant infections in the EU each year. Furthermore, the number of Klebsiella pneumonia cases increased by 31% in 2020 and another 20% in the year 2021. Therefore, the rising prevalence of bacterial infections will drive the diphtheria market.

Companies Innovate And Gain FDA Approval For Diphtheria Prevention Drugs
Companies operating in the diphtheria market are developing innovative drugs and getting approvals to sustain their position in the market. For instance, in October 2022, GlaxoSmithKline plc, a UK-based pharmaceutical and biotechnology company, announced that the US Food and Drug Administration (FDA) approved BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, adsorbed; Tdap) for immunization throughout the third month of the pregnancy to help prevent pertussis (whooping cough) in infants younger than two months of age. The Tdap immunization administered during pregnancy gives the highest protection against whooping cough in the early months of life for newborns. Protective antibodies are transferred from mother to kid when pregnant women are immunized.

The diphtheria market covered in this report is segmented -

1) By Type: Diphtheria; Skin Diphtheria; Other Types
2) By Diagnosis: Physical Examination; Throat Culture; Other Diagnosis
3) By Treatment: Antibiotics; Antitoxin; Other Treatments
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
5) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13016&type=discount

Major players in the diphtheria market are Pfizer Inc., Johnson & Johnson Co, Roche Holding AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Serum Institute of India, Novavax Inc., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Bharat Biotech International Limited, CureVac AG, Inovio Pharmaceuticals Inc., The Native Antigen Company.

Contents of the report:
1. Executive Summary
2. Diphtheria Market Report Structure
3. Diphtheria Market Trends And Strategies
4. Diphtheria Market - Macro Economic Scenario
5. Diphtheria Market Size And Growth
…..
27. Diphtheria Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/diphtheria-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.